BETHANY CORRELLI: Open Payments
NPI 1497353973 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,292 in 58 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $70 · 2025 $1,292
Food & beverage: $1,292
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $322 |
| PFIZER INC. | 11 | $293 |
| Lilly USA, LLC | 9 | $193 |
| AstraZeneca Pharmaceuticals LP | 6 | $121 |
| Dexcom, Inc. | 2 | $53 |
| Phathom Pharmaceuticals, Inc. | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| Exact Sciences Corporation | 2 | $33 |
| ABBVIE INC. | 2 | $31 |
| Indivior Inc. | 1 | $26 |
Products named: NURTEC ODT, Ozempic, MOUNJARO, Wegovy, JARDIANCE, AIRSUPRA, Dexcom G6 Transmitter, BREZTRI.
Industry payments across MD — which companies pay providers there.
